Advanced search×

Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus-mediated gene delivery.

Q Q Kang, M H MH Sun, H H Cheng, Y Y Peng, A G AG Montag, A T AT Deyrup, W W Jiang, H H HH Luu, J J Luo, J P JP Szatkowski, P P Vanichakarn, J Y JY Park, Y Y Li, R C RC Haydon, and T-C TC He

Gene Ther 11(17):1312-20 (2004) PMID 15269709

Efficacious bone regeneration could revolutionize the clinical management of bone and musculoskeletal disorders. Although several bone morphogenetic proteins (BMPs) (mostly BMP-2 and BMP-7) have been shown to induce bone formation, it is unclear whether the currently used BMPs represent the most osteogenic ones. Until recently, comprehensive analysis of osteogenic activity of all BMPs has been hampered by the fact that recombinant proteins are either not biologically active or not available for all BMPs. In this study, we used recombinant adenoviruses expressing the 14 types of BMPs (AdBMPs), and demonstrated that, in addition to currently used BMP-2 and BMP-7, BMP-6 and BMP-9 effectively induced orthotopic ossification when either AdBMP-transduced osteoblast progenitors or the viral vectors were injected into the quadriceps of athymic mice. Radiographic and histological evaluation demonstrated that BMP-6 and BMP-9 induced the most robust and mature ossification at multiple time points. BMP-3, a negative regulator of bone formation, was shown to effectively inhibit orthotopic ossification induced by BMP-2, BMP-6, and BMP-7. However, BMP-3 exerted no inhibitory effect on BMP-9-induced bone formation, suggesting that BMP-9 may transduce osteogenic signaling differently. Our findings suggest that BMP-6 and BMP-9 may represent more effective osteogenic factors for bone regeneration.

Referenced by 1 articles

DOI: 10.1038/sj.gt.3302298
Version: za2963e q8za8 q8zbc q8zc8 q8zd7 q8zed q8zfe q8zg6

Similar articles you may find interesting…

  1. Local immunomodulation with CD4 and CD8 antibodies, but not cyclosporine A, improves osteogenesis induced by ADhBMP9 gene therapy.
    J Z JZ Li, H H Li, ... G A GA Helm

    Gene Ther 12(16):1235-41 (2005) PMID 16034461

    This study was designed to see if immunosuppression achieved using local application of cyclosporine A (Cs. A) or CD4 and CD8 antibodies would improve bone formation following intramuscular injections of human BMP-4 and BMP-9 adenoviral vectors (ADhBMP4 and ADhBMP9) in Sprague-Dawley rats. Cs. A was...
  2. Bone morphogenetic protein 9 induces the transcriptome of basal forebrain cholinergic neurons.
    Ignacio I Lopez-Coviella, Maximillian T MT Follettie, ... Jan Krzysztof JK Blusztajn

    Proc Natl Acad Sci U S A 102(19):6984-9 (2005) PMID 15870197 PMCID 1088172

    We measured gene expression patterns in septal cultures of embryonic day 14 mice and rats grown in the presence or absence of BMP9 by using species-specific microarrays and validated the RNA expression data of selected genes by immunoblot and immunocytochemistry analysis of their protein products. B...
    View PDF
  3. Bone morphogenetic protein 9 is a potent anabolic factor for juvenile bovine cartilage, but not adult cartilage
    Robert L RL Hills, Leona M LM Belanger, and Elisabeth A EA Morris

    J Orthop Res 23(3):7 (2005) PMID 15885482

    Members of the bone morphogenetic protein (BMP) group of the TGF-beta superfamily have been shown to enhance matrix synthesis and maintain cartilage phenotype in long-term culture. These proteins have also been shown to augment cartilage repair in vivo, and may be of potential therapeutic benefit in...